drugset / Trial / NCT01144312
Population Pharmacokinetics of Fentanyl in Patients Undergoing Living Donor Liver Transplantation
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of this study was to characterize pharmacokinetics of fentanyl during and after Living Donor Liver Transplantation (LDLT), using population pharmacokinetic analysis with non linear mixed effects modeling.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-09
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 250 ug | Intravenous |
| Subject | Fentanyl | Other / unclassified | 400 ug | Intravenous |
Indications
No indication recorded.